Obesity accelerates cardiovascular ageing

Eur Heart J. 2025 Jun 16;46(23):2161-2185. doi: 10.1093/eurheartj/ehaf216.

Abstract

A global obesity pandemic, coupled with an increasingly ageing population, is exacerbating the burden of cardiovascular disease. Indeed, clinical and experimental evidence underscores a potential connection between obesity and ageing in the pathogenesis of various cardiovascular disorders. This is further supported by the notion that weight reduction not only effectively reduces major cardiovascular events in elderly individuals but is also considered the gold standard for lifespan extension, in obese and non-obese model organisms. This review evaluates the intricate interplay between obesity and ageing from molecular mechanisms to whole organ function within the cardiovascular system. By comparatively analysing their characteristic features, shared molecular and cell biological signatures between obesity and ageing are unveiled, with the intent to shed light on how obesity accelerates cardiovascular ageing. This review also elaborates on how emerging metabolic interventions targeting obesity might protect from cardiovascular diseases largely through antagonizing key molecular mechanisms of the ageing process itself. In sum, this review aims to provide valuable insight into how understanding these interconnected processes could guide the development of novel and effective cardiovascular therapeutics for a growing aged population with a concerning obesity problem.

Keywords: Autophagy; Caloric restriction; Cardiovascular disease; GLP-1; Inflammation; Mitochondrial dysfunction; SGLT2; Senescence.

Publication types

  • Review

MeSH terms

  • Aging* / physiology
  • Animals
  • Cardiovascular Diseases* / etiology
  • Cardiovascular Diseases* / physiopathology
  • Humans
  • Obesity* / complications
  • Obesity* / physiopathology